Biogen Inc.
BIIB
$131.95
$3.953.09%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 8.77% | -38.87% | 6.81% | 670.48% | -1.35% |
| Total Depreciation and Amortization | 22.28% | 24.20% | 31.33% | 46.24% | 35.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 68.85% | -29.83% | 4.10% | -40.98% | 178.92% |
| Change in Net Operating Assets | -318.66% | -45.82% | 104.37% | -25.64% | -44.08% |
| Cash from Operations | -74.29% | -53.13% | 5,987.20% | 57.93% | 28.50% |
| Capital Expenditure | 20.60% | 19.17% | 39.72% | 52.83% | 52.82% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 100.00% | 83.04% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -106.08% | 49.25% | 508.82% | -101.53% | 173.26% |
| Cash from Investing | -112.22% | 28.33% | 97.15% | 32.21% | 161.91% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -600.00% | -- | 100.00% | 100.00% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.08% | 41.92% | 102.56% | -158.41% | 148.98% |
| Cash from Financing | 95.23% | 94.77% | 101.22% | -100.78% | -2,402.04% |
| Foreign Exchange rate Adjustments | 642.06% | 248.48% | -255.32% | 247.74% | -207.32% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -80.77% | 811.43% | 154.59% | 36.44% | 397.61% |